BTK inhibitor + anti-CD19 CAR-T cells regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BTK inhibitor + anti-CD19 CAR-T cells regimen, covering 2023-02-24 to 2023-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells [Phase 2]